Table 5.

Trying kwt

	1 (n = 6)	2 (n = 10)	3 (n = 13)	p
Anti-Xa BA				0.314
Mean (SD)	0.0133 (0.0103)	0.0250 (0.0237)	0.0108 (0.0144)
Median (Q1, Q3)	0.0200 (0.0050, 0.0200)	0.0300 (0.0000, 0.0400)	0.0000 (0.0000, 0.0200)
Min–max	0.0000–0.0200	0.0000–0.0600	0.0000–0.0400
Missing values	0	0	0
Anti-Xa SDA				0.344
Mean (SD)	0.2317 (0.0906)	0.1920 (0.0699)	0.1682 (0.0710)
Median (Q1, Q3)	0.2350 (0.1625, 0.2925)	0.2000 (0.1250, 0.2375)	0.1400 (0.1200, 0.1600)
Min–max	0.1200–0.3500	0.1000–0.3100	0.1060–0.3200
Missing values	0	0	0
DTanti-Xa range				0.344
Mean (SD)	0.2183 (0.0906)	0.2580 (0.0699)	0.2818 (0.0710)
Median (Q1, Q3)	0.2150 (0.1575, 0.2875)	0.2500 (0.2125, 0.3250)	0.3100 (0.2900, 0.3300)
Min–max	0.1000–0.3300	0.1400–0.3500	0.1300–0.3440
Missing values	0	0	0

BA, before application; DT, difference till; SDA, after subtherapeutic dose application